SLC66A1L: A Potential Drug Target and Biomarker for Uncharacterized Protein C3orf55

Target Name: SLC66A1L

NCBI ID: G152078

SLC66A1L

SLC66A1L: A Potential Drug Target and Biomarker for Uncharacterized Protein C3orf55

Introduction

Uncharacterized protein C3orf55 is a gene that encodes a protein involved in various cellular processes. The protein has not been clearly described in terms of physicochemical properties and functions, and is therefore considered a potential drug target or biomarker. SLC66A1L is a gene related to C3orf55, which plays an important role in organisms. In this article, we discuss the properties of SLC66A1L and its potential as a drug target or biomarker.

Properties of SLC66A1L

SLC66A1L is a gene located on human chromosome 66. The protein encoded by this gene consists of 614 amino acids and is a member of the glycoprotein family. Glycoproteins are complex proteins composed of sugars and proteins. They play important biological functions in organisms, such as cell recognition, signal transmission, and immune response.

Variations in the SLC66A1L gene

Variations in the SLC66A1L gene have been reported to be involved in the pathogenesis of some diseases. For example, studies have found that mutations in the SLC66A1L gene are related to the occurrence of various cancers, including lung cancer, liver cancer, breast cancer, etc. In addition, mutations in the SLC66A1L gene are also associated with neurological diseases, cardiovascular diseases, diabetes and other diseases.

Drug target or biomarker potential of SLC66A1L

As a potential drug target or biomarker, SLC66A1L has a variety of biological properties. First, the protein encoded by the SLC66A1L gene plays an important role in various cancers. Therefore, drug intervention targeting the SLC66A1L gene may be of great significance in the treatment of cancer. In addition, variations in the SLC66A1L gene are associated with a variety of neurological diseases, cardiovascular diseases, diabetes and other diseases. Therefore, by inhibiting the function of the SLC66A1L gene, the incidence of these diseases can be reduced and new ideas for the treatment of these diseases can be provided.

Biomarker potential of SLC66A1L

Variations in the SLC66A1L gene are associated with a variety of diseases and therefore can serve as a potential biomarker. By detecting mutations in the SLC66A1L gene, early diagnosis and treatment of various diseases can be achieved. In addition, variations in the SLC66A1L gene can also be used as biomarkers to evaluate the effect of drug intervention.

in conclusion

SLC66A1L is a gene associated with various diseases. By studying the properties and functions of the SLC66A1L gene, it can be discovered as a potential drug target or biomarker. Future research will focus on the function and drug intervention of the SLC66A1L gene, with a view to providing new ideas for the treatment of various diseases.

Protein Name: Solute Carrier Family 66 Member 1 Like

The "SLC66A1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC66A1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets